Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.

Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, Subramanian S.

Orphanet J Rare Dis. 2013 Jan 11;8:7. doi: 10.1186/1750-1172-8-7.

2.

Prognostic and predictive biomarkers of canine osteosarcoma.

Selvarajah GT, Kirpensteijn J.

Vet J. 2010 Jul;185(1):28-35. doi: 10.1016/j.tvjl.2010.04.010. Epub 2010 May 20. Review.

PMID:
20493743
3.

Comparative biology of human and canine osteosarcoma.

Mueller F, Fuchs B, Kaser-Hotz B.

Anticancer Res. 2007 Jan-Feb;27(1A):155-64. Review.

4.

Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis.

Kushlinskii NE, Fridman MV, Braga EA.

Biochemistry (Mosc). 2016 Apr;81(4):315-28. doi: 10.1134/S0006297916040027. Review.

PMID:
27293089
5.

Prognostic value of microRNAs in osteosarcoma: A meta-analysis.

Kim YH, Goh TS, Lee CS, Oh SO, Kim JI, Jeung SH, Pak K.

Oncotarget. 2017 Jan 31;8(5):8726-8737. doi: 10.18632/oncotarget.14429. Review.

6.

MicroRNAs for osteosarcoma in the mouse: a meta-analysis.

Chang J, Yao M, Li Y, Zhao D, Hu S, Cui X, Liu G, Shi Q, Wang Y, Yang Y.

Oncotarget. 2016 Dec 20;7(51):85650-85674. doi: 10.18632/oncotarget.13333. Review.

7.

What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

Palmini G, Marini F, Brandi ML.

Molecules. 2017 Mar 7;22(3). pii: E417. doi: 10.3390/molecules22030417. Review.

8.

The Molecular Genetic Expression as a Novel Biomarker in the Evaluation and Monitoring of Patients With Osteosarcoma-Subtype Bone Cancer Disease.

Hutanu D, Popescu R, Stefanescu H, Pirtea L, Candea A, Sarau C, Boruga O, Mehdi L, Ciuca I, Tanasescu S.

Biochem Genet. 2017 Aug;55(4):291-299. doi: 10.1007/s10528-017-9801-1. Epub 2017 Apr 19. Review.

PMID:
28425009
9.

Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.

Ram Kumar RM, Boro A, Fuchs B.

Int J Mol Sci. 2016 Jun 3;17(6). pii: E877. doi: 10.3390/ijms17060877. Review.

10.

Review of microRNA in osteosarcoma and chondrosarcoma.

Chang L, Shrestha S, LaChaud G, Scott MA, James AW.

Med Oncol. 2015 Jun;32(6):613. doi: 10.1007/s12032-015-0613-z. Epub 2015 Apr 26. Review.

PMID:
25920607
11.

A review of the association between osteosarcoma metastasis and protein translation.

Osborne TS, Khanna C.

J Comp Pathol. 2012 Feb-Apr;146(2-3):132-42. doi: 10.1016/j.jcpa.2011.12.007. Epub 2012 Jan 31. Review.

12.

MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Miao J, Wu S, Peng Z, Tania M, Zhang C.

Tumour Biol. 2013 Aug;34(4):2093-8. Review.

PMID:
23797816
13.

Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.

Chen D, Liu D, Chen Z.

Tumour Biol. 2017 Sep;39(9):1010428317705762. doi: 10.1177/1010428317705762. Review.

PMID:
28933259
14.

Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.

Varshney J, Scott MC, Largaespada DA, Subramanian S.

Vet Sci. 2016 Jan 18;3(1). pii: E3. doi: 10.3390/vetsci3010003. Review.

15.

Dog models of naturally occurring cancer.

Rowell JL, McCarthy DO, Alvarez CE.

Trends Mol Med. 2011 Jul;17(7):380-8. doi: 10.1016/j.molmed.2011.02.004. Epub 2011 Mar 24. Review.

Supplemental Content

Support Center